Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
AstraZeneca
Julphar
Farmers Insurance
Moodys
Fuji
Citi
Cipla
QuintilesIMS

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,063,802

« Back to Dashboard

Summary for Patent: 6,063,802
Title: Ondansetron freeze-dried dosage form compositions for oral administration
Abstract:The invention relates to a freeze-dried dosage form for oral administration capable of being rapidly disintegrated in the mouth comprising ondansetron in the form of its free base or a pharmaceutically acceptable solvate thereof and one or more pharmaceutically acceptable excipients. Methods for the manufacture of such compositions and for their use in the treatment of conditions mediated through the action of 5-hydroxytryptamine (5HT) at 5HT.sub.3 receptors are also described.
Inventor(s): Winterborn; Ian Keith (Ware, GB)
Assignee: Glaxco Wellcome Inc. (Mississauga, CA)
Application Number:09/238,165
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

Drugs Protected by US Patent 6,063,802

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,063,802

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9423511Nov 22, 1994

International Patents Family Members for US Patent 6,063,802

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
United Kingdom 9523667 ➤ Try a Free Trial
United Kingdom 2295318 ➤ Try a Free Trial
France 2727016 ➤ Try a Free Trial
Finland 119355 ➤ Try a Free Trial
Finland 972167 ➤ Try a Free Trial
Spain 2147309 ➤ Try a Free Trial
European Patent Office 0793495 ➤ Try a Free Trial
Czech Republic 285250 ➤ Try a Free Trial
Denmark 0793495 ➤ Try a Free Trial
Germany 69517332 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Teva
US Department of Justice
Chinese Patent Office
Daiichi Sankyo
McKesson
Fuji
QuintilesIMS
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot